- Home
- WGS vs GAB Comparison
WGS vs GAB Comparison
Compare WGS & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGS
- GAB
- Stock Information
- Founded
- WGS 2017
- GAB 1986
- Country
- WGS United States
- GAB United States
- Employees
- WGS N/A
- GAB N/A
- Industry
- WGS Retail: Computer Software & Peripheral Equipment
- GAB Investment Managers
- Sector
- WGS Technology
- GAB Finance
- Exchange
- WGS Nasdaq
- GAB Nasdaq
- Market Cap
- WGS 1.5B
- GAB 1.6B
- IPO Year
- WGS N/A
- GAB N/A
- Fundamental
- Price
- WGS $68.43
- GAB $5.53
- Analyst Decision
- WGS Strong Buy
- GAB
- Analyst Count
- WGS 5
- GAB 0
- Target Price
- WGS $67.00
- GAB N/A
- AVG Volume (30 Days)
- WGS 753.8K
- GAB 667.8K
- Earning Date
- WGS 10-29-2024
- GAB 01-01-0001
- Dividend Yield
- WGS N/A
- GAB 10.91%
- EPS Growth
- WGS N/A
- GAB N/A
- EPS
- WGS N/A
- GAB N/A
- Revenue
- WGS $267,228,000.00
- GAB N/A
- Revenue This Year
- WGS $43.70
- GAB N/A
- Revenue Next Year
- WGS $16.78
- GAB N/A
- P/E Ratio
- WGS N/A
- GAB N/A
- Revenue Growth
- WGS 29.41
- GAB N/A
- 52 Week Low
- WGS $1.29
- GAB $4.56
- 52 Week High
- WGS $89.11
- GAB $5.88
- Technical
- Relative Strength Index (RSI)
- WGS 51.05
- GAB 54.45
- Support Level
- WGS $71.45
- GAB $5.33
- Resistance Level
- WGS $82.18
- GAB $5.63
- Average True Range (ATR)
- WGS 7.58
- GAB 0.06
- MACD
- WGS -1.36
- GAB 0.01
- Stochastic Oscillator
- WGS 17.21
- GAB 66.67
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.